The research focuses on improving bladder cancer grading by addressing variability in how pathologists categorize tumors into low-grade or highgrade. The challenge lies in the subjectivity of grading, which can lead to differing treatment decisions, impacting patient outcomes. This study aims to create an objective, reproducible grading system through AI-driven image analysis.

How Visiopharm’s Discovery software helps
Visiopharm’s Discovery software enables the automated analysis of millions of nuclei, overcoming the limitations of manual grading.

Download the one-pager